Pliant Therapeutics has discontinued a pivotal Phase 2b/3 clinical trial evaluating bexotegrast as an IPF treatment.
As a measles outbreak appears in the U.S., columnist Sam Kirton and other transplant patients are advised to be on their guard.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback